Global Retirement Partners’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,122
Closed -$193K 2023
2021
Q3
$193K Buy
1,122
+1,082
+2,705% +$142K 0.02% 477
2021
Q2
$5K Buy
40
+28
+233% +$3.53K ﹤0.01% 1608
2021
Q1
$2K Buy
12
+5
+71% +$646 ﹤0.01% 1691
2020
Q4
$1K Hold
7
﹤0.01% 1717
2020
Q3
$1K Hold
7
﹤0.01% 1608
2020
Q2
$1K Buy
+7
New +$675 ﹤0.01% 1586

Global Retirement Partners's XLRN Position: Q4 2021 in Review

Global Retirement Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,122 shares — an estimated $193K sold.

Global Retirement Partners first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $193K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Global Retirement Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Global Retirement Partners sold 1,122 Acceleron Pharma shares in Q4 2021, an estimated $193K.
  • Global Retirement Partners first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
  • Global Retirement Partners's Acceleron Pharma position peaked at $193K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Global Retirement Partners's 13F filing for Q4 2021, filed 21 Jan 2022.